Skip to content
Screener

uniQure QURE Business Segments — Operating Income

Similar metrics at other companies

Alumis Inc. logo
ALMSSingle Reportable — Operating Income
-$98.41M+3.1%
Immunome logo
IMNMSingle Reportable — Operating Income
-$59.33M-32.9%
Capricor Therapeutics logo
CAPRSingle Reportable — Operating Income
-$36.77M-47.2%
LQD
LQDASingle Reportable — Operating Income
$61.5M+274%
Edgewise Therapeutics, Inc. logo
EWTXSingle Reportable — Operating Income
-$54.12M-17.7%
Theravance Biopharma logo
TBPHSingle Reportable — Operating Income
-$9.48M+34.3%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Information technology system costs(2)(1,427)(838)(3,086)(1,839)
Facility expenses(1,437)(1,704)(2,984)(3,371)
Other segment items(1) (2)(2,511)(1,804)(6,024)(2,773)
Segment operating loss(35,637)(32,326)(74,848)(66,636)
Reconciliation
Depreciation and amortization expense(4,907)(3,630)(7,863)(8,157)
Share-based compensation expense(5,016)(5,084)(10,106)(9,494)
Fair value (loss) / gain - contingent consideration(1,256)(2,254)82(3,470)

Item 1.Financial Statements

FAQ

What is uniQure's business segments — operating income?
uniQure (QURE) reported business segments — operating income of -$35.64M in Q2 2026.
How has uniQure's business segments — operating income changed year-over-year?
uniQure's business segments — operating income decreased by 10.2% year-over-year, from -$32.33M to -$35.64M.
What is the long-term trend for uniQure's business segments — operating income?
Over 3 years (2022 to 2025), uniQure's business segments — operating income has grown at a 16.1% compound annual growth rate (CAGR), from -$91.99M to -$144.06M.
What does business segments — operating income mean?
Measures the profitability of the primary business segment by subtracting operating expenses from segment revenue. It is the core indicator of the segment's ability to generate sustainable value from its primary research and development activities.

Ask your AI about uniQure's business segments — operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude